NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Price Target & More

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, May, 3rd. The software maker reported $0.16 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.17 by $0.01. The software maker had revenue of $518.60 million for the quarter, compared to analyst estimates of $527.34 million. Allscripts Healthcare Solutions had a positive return on equity of 7.80% and a negative net margin of 11.34%. Allscripts Healthcare Solutions's revenue for the quarter was up 24.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.13 EPS. View Allscripts Healthcare Solutions' Earnings History.

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 1st 2018. View Earnings Estimates for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $0.72-0.82 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.77. The company issued revenue guidance of $2.15-2.25 billion, compared to the consensus revenue estimate of $2.19 billion.

16 brokerages have issued 12 month price objectives for Allscripts Healthcare Solutions' stock. Their predictions range from $12.00 to $19.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $16.3420 in the next twelve months. View Analyst Ratings for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions saw a decrease in short interest in May. As of May 15th, there was short interest totalling 14,902,389 shares, a decrease of 9.3% from the April 30th total of 16,428,172 shares. Based on an average trading volume of 3,032,726 shares, the short-interest ratio is currently 4.9 days. Approximately 8.5% of the company's stock are short sold. View Allscripts Healthcare Solutions' Current Options Chain.

Some companies that are related to Allscripts Healthcare Solutions include CSRA (CSRA), Scientific Games (SGMS), CACI INTERNATIONAL INC Common Stock (CACI), Science Applications International (SAIC), Verint Systems (VRNT), Ebix (EBIX), NetScout Systems (NTCT), Convergys (CVG), Quality Systems (QSII), Sykes Enterprises (SYKE), VASCO Data Security International (VDSI), Unisys (UIS), Ribbon Communications (RBBN), KEYW (KEYW) and Simulations Plus (SLP).

Press coverage about MDRX stock has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Allscripts Healthcare Solutions earned a coverage optimism score of 0.07 on Accern's scale. They also gave media coverage about the software maker an impact score of 46.21 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Allscripts Healthcare Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (5.66%), Iridian Asset Management LLC CT (4.02%), Fiduciary Management Inc. WI (3.92%), Fisher Asset Management LLC (2.92%), Silvercrest Asset Management Group LLC (2.49%) and Neuberger Berman Group LLC (1.79%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Michael Klayko, Paul Black and Richard J Poulton. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, Dalton Greiner Hartman Maher & Co., Mesirow Financial Investment Management Equity Management, Monarch Partners Asset Management LLC, Sei Investments Co., Blue Harbour Group L.P., Victory Capital Management Inc. and Hsbc Holdings PLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, James Hewitt, Paul Black and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

MDRX stock was bought by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Silvercrest Asset Management Group LLC, Fort Washington Investment Advisors Inc. OH, UBS Group AG, Federated Investors Inc. PA, Fiduciary Management Inc. WI, Wesbanco Bank Inc. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDRX stock can currently be purchased for approximately $12.13.

Allscripts Healthcare Solutions has a market capitalization of $2.15 billion and generates $1.81 billion in revenue each year. The software maker earns $-152,600,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 8,900 workers across the globe.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 312-506-1200 or via email at [email protected]